Abstract
Transcatheter aortic valve implantation (TAVI) has become a paradigm shift in the treatment of elderly and frail patients with severe aortic stenosis, offering a minimally invasive alternative to conventional surgical aortic valve replacement. As the indications for TAVI expand to include lower-risk patients, there is a growing need for sophisticated patient assessment methodologies that capture the complex interplay between physical and functional status, quality of life, and treatment outcomes. This review aims to synthesize the current evidence on the use of patient-reported outcome measures (PROMs) and frailty assessments before and after TAVI, with a focus on their utility in predicting treatment outcomes and improving patient-centered care. A comprehensive literature search was conducted to identify studies published in peer-reviewed journals that investigated the use of PROMs and frailty assessments in the context of TAVI. The review found that PROMs and frailty assessments are increasingly being used to evaluate the pre- and post-procedural status of patients undergoing TAVI. These assessments have been shown to predict treatment outcomes, including mortality, morbidity, and quality of life, and to inform treatment decisions. The review also highlights the importance of integrating PROMs and frailty assessments into routine clinical practice to optimize patient outcomes and improve patient-centered care. In conclusion, this review demonstrates the growing body of evidence supporting the use of PROMs and frailty assessments in the context of TAVI. By incorporating these assessments into routine clinical practice, healthcare providers can better identify patients at risk of poor outcomes, optimize treatment strategies, and improve patient-centered care. Future research should focus on developing and validating PROMs and frailty assessments that are specific to the TAVI population and on exploring the impact of these assessments on treatment outcomes and healthcare utilization.